Significant Ownership of BRISTOL MYERS SQUIBB CO
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for BRISTOL MYERS SQUIBB CO focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Amy Fallone - Amy Fallone / Corporate Secretary
- Manager location
- Princeton, NJ
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow BRISTOL MYERS SQUIBB CO with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from BRISTOL MYERS SQUIBB CO
Significant Ownership of BRISTOL MYERS SQUIBB CO
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CGEN | COMPUGEN LTD | Ordinary Shares, par value NIS 0.01 | 2.1% | $2,723,401 | 1,840,136 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 | ||
| CELU | Celularity Inc | Class A Common stock, par value $0.0001 per share | 1.9% | $174,813 | 426,372 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 | ||
| QTTB | Q32 Bio Inc. | Common stock, par value $0.0001 per share | 1.6% | $312,381 | 200,244 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 |
Schedules 13D/G Reported by BRISTOL MYERS SQUIBB CO:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.